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The scope of my talk as represented by its title
encompasses a very large field which time does not
allow me to cover in its entirety. Therefore, I will
limit my remarks to one very specific area where
chemical changes in amniotic fluid could be used to
predict fetal maturity.
An ever present dilemma in modern obstetrical
management is the proper timing of delivery of the
fetus in situations where complications either threaten
its own life in utero or significantly affect maternal
morbidity. In such situations the obstetrician is confronted with the equivocal choice between premature
delivery and the high risk to the fetus of continued
intrauterine existence. In addition, he is placed in
a unique position where any sort of direct communication with one of his "patients," namely the fetus,
is nearly impossible. In the past, the delivery of
obstetrical care to the fetus and the monitoring of
its well-being were possible only through the agency
of the maternal organism. To improve upon this
situation, methods had to be found that would give
a more direct and accurate reflection of fetal status.
Hence, as complete a collection as possible of accurate indices relating to fetal maturity is of great
importance to the obstetrician. Some of the notable
complications of pregnancy in which these indices
would be of value are diabetes, toxemia, erythroblastosis fetalis, and previous poor obstetrical history: for example, cases requiring repeat cesarean
sections or abruptio placentae.
In the late fifties (Jeffccate and Scott, 1959), it
was recognized that the fetus contributed metabolic
products and secretions to the amniotic fluid, and this
encouraged many researchers to investigate a possible correlation between the status of the fetus and
the amniotic fluid constituents. At that time, however, the technique for amniocentesis had not been
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generally accepted, although it has been known
for over two decades, and the progress of research
was slow. With the acceptance of amniocentesis as
an aggressive means of diagnosis, the procedure for
withdrawal of amniotic fluid led to several investigations into fetal maturity indices. Amongst these
were the measurements of amniotic fluid creatinine
(Pitkin and Zwirek, 1967; Liley, 1961; Mandelbaum, et al, 1967), bilirubin (Droegemueller,
1969), and the examination of the cytology of cells
stained with Nile Blue Sulfate (Brosens and Gordon, 1966; Anderson and Griffiths, 1968). These
indices are now used in a fairly routine manner in
the management of obstetrical patients, and I shall
not go into any detail about them. A further and
more specialized offshoot of this research has been
the measurement of certain other specific amniotic
fluid constituents that might lead, in the near future,
to a more reliable picture of fetal well-being or
distress in addition to fetal maturity.
In spite of all the advances that have been made,
there still exists an appreciable degree of perinatal
mortality today, the major contributor being respiratory distress due to premature delivery. An estimated 25,000 newborn deaths annually in the United
States are attributed to this cause (Gluck, 1971).
The stage of fetal lung maturity at the time of delivery is of prime importance as it most often
entirely determines the survival or death of the neonate. For the neonate to survive, its lung has to
assume immediate function with the change from
an intra to an extrauterine environment. Thus, in
the case of a pregnancy complicated, for example,
by the presence of maternal diabetes or toxemia, the
obstetrician has to walk a tightrope where he must
maintain, to the best of his ability, a critical balance
between neonatal death due to respiratory distress
(hyaline membrane disease) and the threat of intrauterine demise caused by maternal disease. The
frustrating decision that has to be made is, "When
37

38

BHATNAGAR: CHEMICAL CHANGES IN AMNIOTIC FLUID

is the earliest the obstetrician can deliver a healthy
baby that will survive?"
At the moment, what seems to be a ray of hope
on the horizon for the obstetrician has resulted from
research that was started in the early fifties on the
phospholipid content and its patterns in the fetal
lung. As early as 1929, von Neergaard (von Neergaard, 1929), demonstrated that surface forces contribute significantly to the retractive pressure of the.
lung. At that time he postulated a lung coating to
explain these observations. In 1955, Pattie (Pattie,
1955), showed that pulmonary edema foam contained some substance, or substances, that stabilized
the tiny bubbles seen characteristically in such foam,
and in 1957, Clements (Clements, 1957) and Avery
and Mead (Avery and Mead, 1959) identified a surface tension lowering substance in lung tissue. These
observations, subsequently confirmed by several
workers, led to the conclusive identification of this
surface tension lowering compound, called a surfactant, as being a,,B-dipalmitoyl lecithin.
l am now going to highlight some of the significant laboratory findings that have led us to
the point at which we are today. In 1961, Klaus
and his co-workers (Klaus, et al, 1961) showed
that bovine lung foam contained a mixture of several surface active compounds, the major constituent being dipalmitoyl lecithin. The other surface
active compounds he found were sphingomyelin,
phosphatidyl inositol, phosphatidyl dimethylethanolamine, and lysolecithin. The chemical structures
of some of these compounds are depicted in
Fig. 1. During the sixties, significant details of
the surfactant system were gleaned through the work
of Morgan (Morgan, et al, 1965), Fujiwara (Fujiwara, et al, 1968), and Gluck (Gluck, Kulovich,
et al, 1967, 1970) all working independently.
Morgan and his group worked on the identification
of the various components of the surface active
system in alveolar and whole lung homogenates in
the dog. They found that of the total lipids found
in dog lung, phospholipids constituted the major
group at 7 4.1 % . Of this group, phosphatidyl choline
was the major component. Phosphatidyl ethanolamine, lysophosphatidyl choline, which is lysolecithin, and sphingomyelin were also found, but in
much smaller quantities. These are all surface active
along with dipalmitoyl lecithin or phosphatidyl
choline, but phosphatidyl choline seems to be
by far the major component. As seen in Fig.
1, the lecithins are characterized by fatty acid groups
Ri and R 2 on the a and ,B positions of the triglyceride backbone. Fujiwara and his associates
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Fig. I-Chemical structures of some phospholipids.

(Fujiwara, et al, 1968) reported on the significance
of these fatty acids, which are normally C14 to C1s
fatty acids, and the total concentration of individual
phospholipids in the developing fetal lamb lung.
He took fetuses at three different ages of gestation; immature (99-119 days) , transitional (120134 days) and term (135-145 days) . Gestational
age in sheep is about 140 days. He found that
as gestation proceeded toward term, the amount
of phospholipids, both on a weight basis and
on a total phospholipid basis, increased. He also
found that phosphatidyl choline increased while
phosphatidyl ethanolamine decreased, and this will
be an important factor when we talk about the biosynthetic pathways. The significance of the fatty
acids was demonstrated by the observation that the
percentage of saturated fatty acids in the whole
molecule increased towards term, whereas the percentage of saturated fatty acids at the f3 position
stayed fairly constant. This means that now we have
two parameters by which the state of development
of the fetal lung can be assessed; in general, the
total amount of lecithin present and specifically, the
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amount of lecithin esterified with saturated fatty
acids. To test the hypothesis that lung maturity is
reflected by an increase in saturated lecithins, and
vice versa, Brumley and his colleagues measured
the surface tension and phospholipid content of
normal lungs and lungs from infants with respiratory distress syndrome (Brumley, et al, 1967).
Brumiey's data is shown in Table 1. As I men-

they parallel one another and coritiriue to do so
until about the 25th week of gestation where lecithin starts rising slightly more rapidly than. sphingomyelin. At about the 30th to 34th week there is
a sharp increase in lecithin concentration till term,
whereas sphingomyelin plateaus and starts going
dowrt again. The reason for this dramatic rise in
lecithin biosynthesis at about the 32nd to 34th week

TABLE 1
Phospholipid Analysis of Lung Tissue*

Condition
Infants with respiratory
distress
Infants recovered from
respiratory distress
Infants without respiratory
distress
Normal adults

Phospholipid
(mg/ g wet weight)

Phosphatidyl choline
(as % of total
phospholipid)

Saturated fatty acids
(as % in phdsphatidyl
choline)

10.4

46.4

64.7

17 . 4

56.9

70.4

3.0

22.3
16.8

58.8
45 .8

84.2
80.8

6.0
6.0

Surface Tension
(dynes / cm)
23

~ata adapted from Brumley, Hodson, and Avery, 1967.
tioned earlier, what the surfactant does is lower
surface tension and thus produce more elasticity
in the lung. in adults the surface tension of trachial
aspirates is somewhere of the order of 6 dynes/ cm.,
and the total phospholipid content is 16.8 mg/gm
wet weight. The content of phosphatidyl choline, as
a percentage of total phospholipids, is about 45.8%.
In the infant with no respiratory distress syndrome
these values are very close to those in the normal
adult. With respiratory distress syndrome the surface tension of trachial aspirates becomes much
higher. The amount of phospholipid is considerably
lower compared to that of adults and infants with
no respiratory distress syndrome, as are the amounts
of phosphatidyl choline and saturated fatty acid. As
the neonate recovers from the respiratory distress
situation, these values slowly start returning to
normal. This means that there is a valid justification
for implicating the amount of phospholipid, specifically phosphatidyl cholille, in the development of
fetal lung. Gluck and his group (Gluck, 1971;
Gluck, Kulovich, et al, 1967, 1970) reported
extensively in the middle and late sixties on the
biochemistry of surfactant production in the lung.
They measured the amount of dipalmatoyl lecithin
and sphingomyelin in amniotic fluid in humans
(Gluck, 1971), with the results shown in Fig. 2. Gluck
found that early in gestation, the amount of lecithin
is slightly lower than that of sphingomyelin but that

can be partially explained by the.picture of the biosynthetic pathways of these phosph9lipids (Fig. 3).
The lecithins are synthesized niainly by two .routes.
In pathway 1 (the ch9line incorporation pathway)
an a,,B-di-substituted d~glyceride reacts with cytidinediphospho choline (CDP-choline) thereby incorporating choline into the molecule which results in
phosphatidyl choline, or lecithin: In pathway 2 (the
methylatidn pathway) the a,,B-diglyceride incorporates
ethanolamine through the agency of cytidine-diphosphoethanolainine ( CDP-ethanolarriine) resulting in
phosphatidyl ethanolamine (PE) which by subsequent
methylations by S-adenosyltnethionine gives phos7
phatidyl methyl ethanolamine (PME) , phosphatidyl
dimethyl <;:thanolamine (PDME), and finally lecithin.
These two pathways need to be studied in greater
detail than they have been, but certain facets about
them are known. It has been shown that the dramatic
surge in lecithin at the 33rd to 34th week appears
because of the activation of pathway 1, that is, the
choline incorporation pathway. Gluck has evidence,
primarily clinical in nature, that the methylation
pathway is the primary mode of lecithin biosynthesis
in early gestation, but that on .or after about the 34th
week, the choline incorporation pathway becomes
the more important (Gluck, 1971). He found that
when he analyzed respiratory distress syndrome
cases in prematures, most of them were acidotic
and/or hypothermic. He also found that neither
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acidosis nor hypothermia were associated with
clinical respiratory distress syndrome in the full-term
infant. When trachial aspirates were obtained from
prenatal, or frbm premature infants while they were
still hypothermic, he found little or no phosphatidyl
dimethyl ethancilamine which meant that the inethylation pathway was not functioning. As the infants
were put into an incubator and temperature brought
up, increasing amounts of PDME were found in
trachial aspirates which indicated that the heat supplied to them was activating this pathway. These
findings suggested that the methylation pathway is
vulnerable to external insult. Yet if this were the case,
then some full-term infants should also show respiratory distress, which they do not. Gluck's explanation for this is based on his evidence that
early in gestation the methylation pathway is the
more important btit at about the 35th week the
choline incorporation pathway takes over causing the
surge of lecithin. As the choiine incorporation pathway is not vulnerable to external insult, it is producing sufficient quantities of surfactant for the
full-term infant not to have respiratory distress; Thus
the premature infant is at a disadvantage because
at around 30-34 weeks gestation when the methylation pathway is dominant and vulnerable to external
insult, the choline incorporation pathway has not
yet assumed maximal function, and hence, sufficient
surfactant is not being produced. The only lab finding that Gluck reports in support of his hypothesis
is that in vitro, the methylation pathway is markedly
inhibited below a pH of 7.2; in vivo, exposure to
cold or hypothermia or hypoxia causes acidosis in
the neonate, which could then inhibit the methylation pathway.
With all this data, we now have the basis for
developing a method for the prediction of re~
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Fig. 2-ConcentratiOns of sphingomyelin and lecithin in
amniotic fluid during gestation. (Reprinted with permission
from Gluck, Hosp. Pract. 6:45, 1971.)

spiratory distress in the neonate by measuring lecithin and sphingomyelin in amniotic fluid. Although
lecithin and sphingomyelin are measured individually, the results are reported in terms of the- ratio
of lecithin to sphirigomyelin. Once the ratio starts
getting higher than 1 or 2, one might be able to
give some indicatiori about whether respiratory
distress could be predicted in that fetus were it delivered at that time. The method we have developed
and are using at present is a modification of G!uck's
original method (Gluck, Kulovich, et al, 1971) and
is - outlined in Fig. 4. Three inililiters of amniotic
fluid are taken to which are added 3 ml of methanol
and 6 ml of chloroform in a centrifuge tube. The
whole is extracted once, centrifuged, and the lower

©
a,13-0iglyceride

@

CDP- choline

Phosphatidyl choline
(Lecithin)

CDP-ethanolamine

Phosphatidylethanolamine
_(PE)

Phosphatidyl methylethanolamine

Phosphatidyldiinethylethanolamine

(PME)

(PDME)

Fig. 3- Two postulated pathways for lecithin biosynthesis.
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3 ml Amniotic Fluid

l

3 ml Methanol
6 ml Chloroform

Extract once and centrifuge

i
i
i
i

Separate lower Chloroform: Methanol layer

Evaporate and reconstitute in 100 µl Chloroform

Transfer to Silica Gel H TLC Plate

i

Chromatograph in Chloroform-Methanol-Acetic Acid-0.93 aq. NaCl
70
:
25 : 4.8
3.2
a) Place chromatoplate in chamber saturated with iodine vapor
b) Remove chromatoplate from chamber, mark spots, wait for iodine to vaporize
c) Carefully scrape off the silica gel from marked areas

i

Measure phosphorous content by the method of Fiske & Subbarow (Fiske and Subbarow, 1925; King, 1938)

Fig. 4- Methodologic flow sheet.

chloroform methanol layer is removed , evaporated,
and reconstituted in 100 µ,l of chloroform . This is
then transferred to a thin-layer plate which is run in
the system, chloroform-methanol-acetic acid-0.9%
aq. NaO (70:25:4.8:3.2). We found this system to
be better than the old chloroform-methanoi-water
ones which are normally used for phospholipids:
Lecithin and sphingomyelin are visualized by placing
the thin-layer · plate in a chamber saturated with
iodine vapor. The iodine is deposited reversibly on
the areas where the lecithin and sphingomyelin are
located. The spots are then marked, scraped off, and
after the iodine has vaporized, the phosphorus
content of the spots is measured by a modification
of the Fiske and Subbarow method (Fiske and Subbarow, 1925; King, 1938). As one mole of phosphorus corresponds to one mole of lecithin and
sphingomyelin, by measuring the amount of phosphorus, we can calculate the absolute amounts of
lecithin and sphingomyelin and hence get the ratio
of one to the other. The test we have developed
takes an average technician approximately 3 hours
for 6 quantitative determinations. For a quick but
qualitative result, the test can be shortened by
eliminating the quantitative step, spraying the thinlayer plate with a phosphorus specific spray (Ditt-

mer and Lester, 1964) once it comes out of its
developing solvent system, and then estimating in
gross terms the amounts of lecithin and sphingomyelin by the visual intensities of their spots.
In our laboratory, we take a ratio of 2 or
greater tO predict fetal lung maturity. Gluck and his
group reported a few months ago that based on the
results of 302 amniocenteses from 272 pregnancies
using their method of monitoring ·the phospholipids,
not one single case of respiratory distress occurred
(Gluck, Kulovich, et al, 1971). Our experience
here at the Medical College of Virginia is of shorter
duration. After 49 complicated pregnancies which
we have monitored through 63 amniocenteses, we
have noi encountered any instance of respiratory
distress, and among these we have had four notable
cases : three of diabetes and one of Rh disease. The
Rh disease patient was delivered at 331/i weeks after
continuous monitoring of her lecithin-sphingomyelin
ratios, and she delivered a healthy viable infant whose
weight was compatible with dates. The three diabetics were delivered at 34, 35, and 36 weeks, and
all delivered healthy viable infants showing no signs
of respiratory distress.
Although the lecithin-sphingomyelin ratio seems
to be going a long way in alleviating the frustration
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of obstetricians, it should still be used with caution
because the volume of data is not sufficient to show
what would happen if one were to get a false positive, if one indeed ever gets false positives. The next
big step that needs to be taken is a detailed study
of the two major biosynthetic pathways for ledthin
and a study of the characteristics and properties of
the enzymes involved. If a compound could be
found to induce one or both of these enzymes, this
information would provide a much wanted tool in
the hands of an obstetrician or pediatrician for dealing with the fetus or neonate. Such information
would also be of great significance in cases of respiratory distress syndrome which are independent
of obstetrical management, such as premature labor.
In this instance, the physician is confronted with a
situation not of his own making and has to deal with
it as quickly and as best he can. At present, we are
able, with the use of the described test, to predict
the possibility of respiratory distress and thus have
the necessary facilities such as an incubator or a
respirator ready for the neonate immediately after
delivery. But of even greater benefit would be the
discovery of a compound drug which would induce
the choline incorporation pathway. This, as i
mentioned earlier, is insensitive to external insult,
and once biosynthesis of lecithin has been induced
by means of the pathway, the neonate itself can take
over the job it is supposed to do. A further goal
is the compiling of sufficient data such that a significant statistical analysis can be made concerning
the accuracy of predicting the severity of respiratory
distress associated with specific ranges of the
lecithin/ sphingomyelin ratio.
Finally, I would like to express my appreciation to our excellent housestaff who have been very
patient in supplying me with samples of amniotic
fluid as uncontaminated with blood as possible and
also my very deep gratitude to Dr. Dunn for his
constant and very enthusiastic encouragement of this
work.
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